Toll-like receptor 9 signaling has anti-inflammatory effects on the early phase of Helicobacter pylori-induced gastritis

Biochemical and Biophysical Research Communications

Volumn 426, Issue 3, 2012, Pages 342-349

  Otani, Koji ^a   Tanigawa, Tetsuya ^a   Watanabe, Toshio ^a   Nadatani, Yuji ^a   Sogawa, Mitsue ^a   Yamagami, Hirokazu ^a   Shiba, Masatsugu ^a   Watanabe, Kenji ^a   Tominaga, Kazunari ^a   Fujiwara, Yasuhiro ^a   Arakawa, Tetsuo ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Interferon ; Interferon ; Interferon ; Tumor necrosis factor

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; GAMMA INTERFERON; INTERLEUKIN 4; MESSENGER RNA; TOLL LIKE RECEPTOR 9;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CD3+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GASTRITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; INOCULATION; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STOMACH MUCOSA; WILD TYPE;

ANIMALS; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; INTERFERON TYPE I; INTERFERON-ALPHA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SIGNAL TRANSDUCTION; TH1 CELLS; TOLL-LIKE RECEPTOR 9;

BACTERIA (MICROORGANISMS); HELICOBACTER PYLORI; MUS;

EID: 84866901247     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.08.080     Document Type: Article

References (26)

1. Akira S., Hemmi H. Recognition of pathogen-associated molecular patterns by TLR family. Immunol. Lett. 2003, 85:85-95.
2. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., Matsumoto M., Hoshino K., Wagner H., Takeda K., Akira S. A Toll-like receptor recognizes bacterial DNA. Nature 2000, 408:740-745.
3. Beutler B. Innate immunity: an overview. Mol. Immunol. 2004, 40:845-859.
4. Takeda K., Kaisho T., Akira S. Toll-like receptors. Annu. Rev. Immunol. 2003, 21:335-376.
5. Biron C.A. Interferons alpha and beta as immune regulators - a new look. Immunity 2001, 14:661-664.
6. Tanigawa T., Watanabe T., Hamaguchi M., Sasaki E., Tominaga K., Fujiwara Y., Oshitani N., Matsumoto T., Higuchi K., Arakawa T. Anti-inflammatory effect of two isoforms of COX in H. pylori-induced gastritis in mice: possible involvement of PGE2. Am. J. Physiol. Gastrointest. Liver Physiol. 2004, 286:G148-G156.
7. Otani K., Watanabe T., Tanigawa T., Okazaki H., Yamagami H., Watanabe K., Tominaga K., Fujiwara Y., Oshitani N., Arakawa T. Anti-inflammatory effects of IL-17A on Helicobacter pylori-induced gastritis. Biochem. Biophys. Res. Commun. 2009, 382:252-258.
8. Yamato M., Watanabe T., Higuchi K., Taira K., Tanigawa T., Shiba M., Tominaga K., Fujiwara Y., Oshitani N., Takeuchi K., Arakawa T. Anti-inflammatory effects of pravastatin on Helicobacter pylori-induced gastritis in mice. Dig. Dis. Sci. 2007, 52:2833-2839.
9. Mosmann T.R., Coffman R.L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 1989, 7:145-173.
10. Smythies L.E., Waites K.B., Lindsey J.R., Harris P.R., Ghiara P., Smith P.D. Helicobacter pylori-induced mucosal inflammation is Th1 mediated and exacerbated in IL-4, but not IFN-gamma, gene-deficient mice. J. Immunol. 2000, 165:1022-1029.
11. Eaton K.A., Mefford M., Thevenot T. The role of T cell subsets and cytokines in the pathogenesis of Helicobacter pylori gastritis in mice. J. Immunol. 2001, 166:7456-7461.
12. Schmausser B., Andrulis M., Endrich S., Lee S.K., Josenhans C., Muller-Hermelink H.K., Eck M. Expression and subcellular distribution of toll-like receptors TLR4, TLR5 and TLR9 on the gastric epithelium in Helicobacter pylori infection. Clin. Exp. Immunol. 2004, 136:521-526.
13. Lee A., O'Rourke J., De Ungria M.C., Robertson B., Daskalopoulos G., Dixon M.F. A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology 1997, 112:1386-1397.
14. Krawisz J.E., Sharon P., Stenson W.F. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 1984, 87:1344-1350.
15. Bradley P.P., Priebat D.A., Christensen R.D., Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J. Invest. Dermatol. 1982, 78:206-209.
16. Rachmilewitz D., Karmeli F., Takabayashi K., Hayashi T., Leider-Trejo L., Lee J., Leoni L.M., Raz E. Immunostimulatory DNA ameliorates experimental and spontaneous murine colitis. Gastroenterology 2002, 122:1428-1441.
17. Rachmilewitz D., Katakura K., Karmeli F., Hayashi T., Reinus C., Rudensky B., Akira S., Takeda K., Lee J., Takabayashi K., Raz E. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 2004, 126:520-528.
18. Albiger B., Dahlberg S., Sandgren A., Wartha F., Beiter K., Katsuragi H., Akira S., Normark S., Henriques-Normark B. Toll-like receptor 9 acts at an early stage in host defence against pneumococcal infection. Cell. Microbiol. 2007, 9:633-644.
19. Kawai T., Sato S., Ishii K.J., Coban C., Hemmi H., Yamamoto M., Terai K., Matsuda M., Inoue J., Uematsu S., Takeuchi O., Akira S. Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat. Immunol. 2004, 5:1061-1068.
20. Honda K., Yanai H., Mizutani T., Negishi H., Shimada N., Suzuki N., Ohba Y., Takaoka A., Yeh W.C., Taniguchi T. Role of a transductional-transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling. Proc. Natl. Acad. Sci. USA 2004, 101:15416-15421.
21. Negishi H., Fujita Y., Yanai H., Sakaguchi S., Ouyang X., Shinohara M., Takayanagi H., Ohba Y., Taniguchi T., Honda K. Evidence for licensing of IFN-gamma-induced IFN regulatory factor 1 transcription factor by MyD88 in Toll-like receptor-dependent gene induction program. Proc. Natl. Acad. Sci. USA 2006, 103:15136-15141.
22. O'Neill L.A., Bowie A.G. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat. Rev. Immunol. 2007, 7:353-364.
23. Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell 2006, 124:783-801.
24. Barton G.M., Medzhitov R. Linking Toll-like receptors to IFN-alpha/beta expression. Nat. Immunol. 2003, 4:432-433.
25. Katakura K., Lee J., Rachmilewitz D., Li G., Eckmann L., Raz E. Toll-like receptor 9-induced type I IFN protects mice from experimental colitis. J. Clin. Invest. 2005, 115:695-702.
26. Lee J., Rachmilewitz D., Raz E. Homeostatic effects of TLR9 signaling in experimental colitis. Ann. N. Y. Acad. Sci. 2006, 1072:351-355.